Mitochondrial dysfunction in cybrid lines expressing mitochondrial genes from patients with progressive supranuclear palsy.
about
NDUFA12L mitochondrial complex-I assembly factor: Implications for taupathiesGenetics Underlying Atypical Parkinsonism and Related Neurodegenerative DisordersCytoplasmic hybrid (cybrid) cell lines as a practical model for mitochondriopathiesDeregulation of mitochondrial F1FO-ATP synthase via OSCP in Alzheimer's disease.The neurodegenerative mitochondriopathies.Mitochondrial complex 1 inhibition increases 4-repeat isoform tau by SRSF2 upregulation.Cell and animal models of mtDNA biology: progress and prospects.Mitochondrial Medicine and the Neurodegenerative Mitochondriopathies.Role and treatment of mitochondrial DNA-related mitochondrial dysfunction in sporadic neurodegenerative diseases.Neurodegenerative diseases: neurotoxins as sufficient etiologic agents?Mitochondrial toxins in Basal Ganglia disorders: from animal models to therapeutic strategies.Relationship between uric acid levels and progressive supranuclear palsy.Mitochondrial medicine for neurodegenerative diseases.Rational therapeutic approaches to progressive supranuclear palsy.Visual signs and symptoms of progressive supranuclear palsy.Mitochondrial dysfunction as a therapeutic target in progressive supranuclear palsy.Clinical trials: past, current, and future for atypical Parkinsonian syndromes.CoQ10 in progressive supranuclear palsy: A randomized, placebo-controlled, double-blind trial.A Review of Treatment Options for Progressive Supranuclear Palsy.Chronic systemic complex I inhibition induces a hypokinetic multisystem degeneration in rats.Experimental evidence for a toxic etiology of tropical parkinsonism.In vivo evidence for cerebral depletion in high-energy phosphates in progressive supranuclear palsy.Mitochondrial dysfunction in Parkinsonian mesenchymal stem cells impairs differentiation.Short-term effects of coenzyme Q10 in progressive supranuclear palsy: a randomized, placebo-controlled trial.The mitochondrial complex I inhibitor rotenone triggers a cerebral tauopathy.Aging and oxidative stress in progressive supranuclear palsy.The Effects of Cardiotrophin-1 on Early Synaptic Mitochondrial Dysfunction and Synaptic Pathology in APPswe/PS1dE9 Mice.A new noninvasive test to detect mitochondrial dysfunction of skeletal muscles in progressive supranuclear palsy.Traumatic Brain Injury and Firearm Use and Risk of Progressive Supranuclear Palsy Among Veterans.Cybrid Models of Pathological Cell Processes in Different Diseases.
P2860
Q26764822-B8684E0B-A73A-413F-83C7-2CD61CB59171Q26779001-967AF2B3-AD34-4384-8E26-9854E2C15D66Q26859496-EF8A80A6-4C8C-4C8C-ADB9-53EB73B5508FQ33862808-A1E198EA-700E-4982-A0C2-DEC47731BBC9Q33957065-FB062161-BD5B-46AF-A398-C9794E3B575EQ34526836-43F8D6AF-9928-401A-AD7D-43D5F7164A0EQ34569830-3CFC22ED-1354-4992-A126-CF9C23F4B494Q35140660-C85A4578-A828-455F-8F06-6194DC55D01CQ35958359-4B459474-44E8-4B4B-8333-E1B60AF3E119Q36994301-7024116A-9827-467E-A6F5-C2FA8D8400ABQ37211755-8DA70E9E-D030-44C2-AE10-9FFE67B3BB49Q37601192-B0DD5852-E4FB-4ACD-B1A5-0691C317EB57Q37672741-AC417CAC-9907-4699-9B8E-09CDD62E40F1Q37753509-FA78999C-97EB-4B31-B669-FB5C69803E43Q37772535-5A27A98A-4DF0-4D8F-A5E4-F9C5397436E4Q37906364-D0B414DE-9F5D-4FF1-81B2-EE5B089F75E4Q38223118-C6006C1A-6CBE-4BA9-B261-38D37BD4FC1AQ38388068-2C01EC1D-D58F-4D6D-A3E7-D94BF78D63E3Q38843694-49C90B48-ECD6-41FB-A45A-806204A5CEB6Q42436464-4097B18C-E80A-49B0-AD6E-EADF717D9AABQ45076842-D21967F1-5AF3-4BA1-9A33-2CCC9DD97CC2Q46134947-5B380D54-9B6A-4231-A860-84898EC10022Q46142299-7FDE9FFF-4C3E-44BF-9DAE-CF284C86DDCCQ46606421-76B4A09F-E399-4110-9D27-54032C4BF7E3Q46747405-09C13210-6153-4C63-AD6C-563DFCC143E4Q46899416-7E53C947-7627-4C6A-9D4E-F2F29D26F461Q48185451-8A9A9859-7328-4A0F-BB95-CCA597F5A37EQ53581098-6DD466FC-06B8-4823-ADF8-AAAC1912D64CQ55415545-D65C1D29-0113-4150-BA79-AD88143B2002Q55491162-04A188D8-07C1-4676-ABF3-2319840DD3CA
P2860
Mitochondrial dysfunction in cybrid lines expressing mitochondrial genes from patients with progressive supranuclear palsy.
description
2000 nî lūn-bûn
@nan
2000 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Mitochondrial dysfunction in c ...... rogressive supranuclear palsy.
@ast
Mitochondrial dysfunction in c ...... rogressive supranuclear palsy.
@en
type
label
Mitochondrial dysfunction in c ...... rogressive supranuclear palsy.
@ast
Mitochondrial dysfunction in c ...... rogressive supranuclear palsy.
@en
prefLabel
Mitochondrial dysfunction in c ...... rogressive supranuclear palsy.
@ast
Mitochondrial dysfunction in c ...... rogressive supranuclear palsy.
@en
P2093
P2860
P1476
Mitochondrial dysfunction in c ...... progressive supranuclear palsy
@en
P2093
A E Grawey
D R Binder
G F Wooten
J P Bennett
R H Swerdlow
W D Parker
P2860
P304
P356
10.1046/J.1471-4159.2000.0751681.X
P407
P577
2000-10-01T00:00:00Z